EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CD30 as a Target Molecule in the Diagnosis and Therapy of Lymphomas

Harald Stein, Brunangelo Falini iD

American Journal of Hematology · 2026

DOI: 10.1002/ajh.70107 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Hematology, 2026. Verfasst von Harald Stein und 1 weiteren Autor:innen. Beteiligte Einrichtung: Past Berlin Reference Pathologist of the German Reference Center for Hematopathology, Berlin, Germany. Hauptthemen laut MEDLINE: Ki-1 Antigen, Lymphoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Umbria contro le Leucemie e i Linfomi (AULL).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor necrosis factor (TNF)‐receptor superfamily 8 receptor CD30 molecule is expressed in all tumor cells of Hodgkin lymphoma and anaplastic large cell lymphoma but is only weakly expressed in a small subset of large lymphoid cells in normal peripheral lymphoid tissues. This makes this molecule an important target for the diagnosis and treatment of CD30‐expressing lymphomas. We describe the road to the discovery of the CD30 molecule and the way CD30 has contributed to more precise diagnosis and classification of lymphomas. Moreover, we address how anti‐CD30 immunotherapy was developed and the impact of the anti‐CD30‐auristatin conjugate and anti‐CD30 CAR‐T cells in treating CD30‐expressing lymphomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ki-1 AntigenLymphomaHumansHodgkin DiseaseImmunoconjugatesImmunotherapy, AdoptiveLymphoma, Large-Cell, Anaplastic

Stichwörter der Autor:innen

CAR‐T cellsCD30Hodgkinantibodiesbrentuximabimmunohistochemistrylymphomas

Substanzen

Ki-1 AntigenImmunoconjugates

Autor:innen und Institutionen

  • Past Berlin Reference Pathologist of the German Reference Center for Hematopathology, Berlin, Germany.
  • Institute of Hematology and Center for Hemato-Oncological Research (CREO), University of Perugia and Santa Maria Della Misericordia Hospital, Perugia, Italy.

ORCID-Profile: Brunangelo Falini

Förderung

  • Associazione Umbria contro le Leucemie e i Linfomi (AULL)

Zitieren

APA

Stein, H., & Falini, B. (2026). CD30 as a Target Molecule in the Diagnosis and Therapy of Lymphomas. American Journal of Hematology. https://doi.org/10.1002/ajh.70107

Vancouver

Stein H, Falini B. CD30 as a Target Molecule in the Diagnosis and Therapy of Lymphomas. American Journal of Hematology. 2026. doi:10.1002/ajh.70107

BibTeX
@article{Stein2026,
  author = {Stein, Harald and Falini, Brunangelo},
  title = {CD30 as a Target Molecule in the Diagnosis and Therapy of Lymphomas},
  journal = {American Journal of Hematology},
  year = {2026},
  doi = {10.1002/ajh.70107}
}
Kostenlos starten →